This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations by Harry O Tobiassen
Introduction
Harry O Tobiassen is a notable inventor based in Ledyard, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of glycogen phosphorylase inhibitors. With a total of 2 patents, Tobiassen's work is instrumental in addressing various health conditions.
Latest Patents
Tobiassen's latest patents include innovative processes and intermediates for preparing glycogen phosphorylase inhibitors. These compounds are crucial in treating diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, and myocardial ischemia. Additionally, he has developed N-(indole-2-carbonyl)-β-alaninamide crystal forms, which further enhance the efficacy of these inhibitors in combating tumor growth.
Career Highlights
Throughout his career, Tobiassen has been associated with Pfizer Corporation, a leading pharmaceutical company. His work has contributed to advancements in medical treatments and has had a positive impact on patient care.
Collaborations
Some of his notable coworkers include Frank R Busch and Susan L Orrill, who have collaborated with him on various projects within the pharmaceutical domain.
Conclusion
Harry O Tobiassen's innovative contributions to the field of pharmaceuticals highlight his dedication to improving health outcomes through scientific research and development. His patents reflect a commitment to addressing critical health issues and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile